Patients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy

1

Review clinical trials related to Patients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

This study is a randomized, open-label, multicenter Phase II clinical study, with the objective to assess the efficacy and safety of JMT101 Injection combined with Mitoxantrone Hydrochloride Liposome Injection in patients with recurrent/metastatic nasopharyngeal cancer who have failed at least two prior lines of treatment.

Participants needed: 150
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: Mar 25, 2025
Eligibility criteria

Able to understand and voluntarily sign the written ICF; [+7]

Previously received EGFR monoclonal antibody therapy for recurrent/metastatic na... [+18]